By analyzing publicly available tumor data from The Cancer Genome Atlas (TCGA), we found that IL-33 and ST2 mRNA is widely expressed in sarcoma, indicating that the IL-33/ST2 axis may play an important role in regulating antitumor immunity in STS. This evidence concerns the gene IL33 and telomere syndrome.